173 related articles for article (PubMed ID: 35188729)
21. Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody.
Zeng S; Wu M; Jin Y; Ye Y; Xia H; Chen X; Che J; Wang Z; Wu Y; Dong X; Chen Y; Huang W
Eur J Med Chem; 2024 Mar; 267():116206. PubMed ID: 38350360
[TBL] [Abstract][Full Text] [Related]
22. Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Shi H; Tang H; Li Y; Chen D; Liu T; Chen Y; Wang X; Chen L; Wang Y; Xie H; Xiong B
Eur J Med Chem; 2023 Feb; 248():115064. PubMed ID: 36621137
[TBL] [Abstract][Full Text] [Related]
23. Discovery of Macrocycle-Based HPK1 Inhibitors for T-Cell-Based Immunotherapy.
Wang MS; Wang ZZ; Li ZL; Gong Y; Duan CX; Cheng QH; Huang W; Yang GF
J Med Chem; 2023 Jan; 66(1):611-626. PubMed ID: 36542759
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses.
Shui JW; Boomer JS; Han J; Xu J; Dement GA; Zhou G; Tan TH
Nat Immunol; 2007 Jan; 8(1):84-91. PubMed ID: 17115060
[TBL] [Abstract][Full Text] [Related]
25. Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.
Ma W; Xia C; Ling P; Qiu M; Luo Y; Tan TH; Liu M
Oncogene; 2001 Mar; 20(14):1703-14. PubMed ID: 11313918
[TBL] [Abstract][Full Text] [Related]
26. Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations.
Ge H; Tang C; Pan Y; Yao X
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768974
[TBL] [Abstract][Full Text] [Related]
27. Interactions between hematopoietic progenitor kinase 1 and its adaptor proteins (Review).
Zhang Q; Ding S; Zhang H
Mol Med Rep; 2017 Nov; 16(5):6472-6482. PubMed ID: 28901492
[TBL] [Abstract][Full Text] [Related]
28. HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion.
Patzak IM; Königsberger S; Suzuki A; Mak TW; Kiefer F
Eur J Immunol; 2010 Nov; 40(11):3220-5. PubMed ID: 20957749
[TBL] [Abstract][Full Text] [Related]
29. MAP4K Family Kinases in Immunity and Inflammation.
Chuang HC; Wang X; Tan TH
Adv Immunol; 2016; 129():277-314. PubMed ID: 26791862
[TBL] [Abstract][Full Text] [Related]
30. Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors.
Lacey BM; Xu Z; Chai X; Laskey J; Fradera X; Mittal P; Mishra S; Piesvaux J; Saradjian P; Shaffer L; Vassileva G; Gerdt C; Wang Y; Ferguson H; Smith DM; Ballard J; Wells S; Jain R; Mueller U; Addona G; Kariv I; Methot JL; Bittinger M; Ranganath S; Mcleod R; Pasternak A; Miller JR; Xu H
SLAS Discov; 2021 Jan; 26(1):88-99. PubMed ID: 32844715
[TBL] [Abstract][Full Text] [Related]
31. Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1.
Zhou G; Boomer JS; Tan TH
J Biol Chem; 2004 Nov; 279(47):49551-61. PubMed ID: 15364934
[TBL] [Abstract][Full Text] [Related]
32. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.
Ling P; Meyer CF; Redmond LP; Shui JW; Davis B; Rich RR; Hu MC; Wange RL; Tan TH
J Biol Chem; 2001 Jun; 276(22):18908-14. PubMed ID: 11279207
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK).
Wang X; Li JP; Kuo HK; Chiu LL; Dement GA; Lan JL; Chen DY; Yang CY; Hu H; Tan TH
J Biol Chem; 2012 Mar; 287(14):11037-48. PubMed ID: 22334673
[TBL] [Abstract][Full Text] [Related]
34. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
[TBL] [Abstract][Full Text] [Related]
35. Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance.
Liu J; Curtin J; You D; Hillerman S; Li-Wang B; Eraslan R; Xie J; Swanson J; Ho CP; Oppenheimer S; Warrack BM; McNaney CA; Nelson DM; Blum J; Kim T; Fereshteh M; Reily M; Shipkova P; Murtaza A; Sanjuan M; Hunt JT; Salter-Cid L
PLoS One; 2019; 14(3):e0212670. PubMed ID: 30913212
[TBL] [Abstract][Full Text] [Related]
36. Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade.
Hu MC; Qiu WR; Wang X; Meyer CF; Tan TH
Genes Dev; 1996 Sep; 10(18):2251-64. PubMed ID: 8824585
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.
Wu P; Sneeringer CJ; Pitts KE; Day ES; Chan BK; Wei B; Lehoux I; Mortara K; Li H; Wu J; Franke Y; Moffat JG; Grogan JL; Heffron TP; Wang W
Structure; 2019 Jan; 27(1):125-133.e4. PubMed ID: 30503777
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic progenitor kinase 1 is a component of transforming growth factor beta-induced c-Jun N-terminal kinase signaling cascade.
Zhou G; Lee SC; Yao Z; Tan TH
J Biol Chem; 1999 May; 274(19):13133-8. PubMed ID: 10224067
[TBL] [Abstract][Full Text] [Related]
39. Functional interactions of HPK1 with adaptor proteins.
Boomer JS; Tan TH
J Cell Biochem; 2005 May; 95(1):34-44. PubMed ID: 15770651
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway.
Sawasdikosol S; Pyarajan S; Alzabin S; Matejovic G; Burakoff SJ
J Biol Chem; 2007 Nov; 282(48):34693-9. PubMed ID: 17895239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
